CloudMD Announces Resignation of Director

Rhea-AI Summary

CloudMD Software & Services Inc. (OTCQX: DOCRF) announced the resignation of Mark Kohler as a director and Chair of the Board, effective April 21, 2022, citing personal reasons. The Company expressed gratitude for his contributions during his tenure. CloudMD is focused on transforming healthcare delivery through technology, offering a comprehensive platform that covers all aspects of a patient's healthcare journey, servicing over 5,700 clinicians, including various specialists, and covering 12 million lives across North America.

Positive

• Mark Kohler's resignation allows for new leadership perspectives on the Board.
• CloudMD's focus on technology-driven healthcare solutions positions it well for growth.

Negative

• Mark Kohler's departure may create a gap in leadership continuity.

VANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- CloudMD Software & Services Inc. (TSXV: DOC, OTCQX: DOCRF, Frankfurt: 6PH) (“CloudMD” or the “Company”), a healthcare technology and innovative health services company transforming the delivery of care, announces that Mark Kohler has resigned as a director of the Company and the Chair of the Board, effective April 21, 2022, for personal reasons. The Company thanks Mr. Kohler for his contributions to CloudMD during his tenure on the Board and wishes him all the best in his future endeavours.

About CloudMD Software & Services

CloudMD is transforming the delivery of healthcare using technology and by providing a patient-centric approach, with an emphasis on continuity of care. By leveraging healthcare technology, the Company is building one, connected platform that addresses all points of a patient’s healthcare journey and provides better access to care and improved outcomes. Through CloudMD’s proprietary technology, the Company delivers quality healthcare through a holistic offering including hybrid primary care clinics, specialist care, telemedicine, mental health support, healthcare navigation, educational resources, and artificial intelligence (AI). CloudMD’s business is separated into three main divisions: Clinics and Pharmacies, Digital Solution and Enterprise Health Solutions, the Company’s fastest growing division. CloudMD’s Enterprise Health Solutions Division has built a leading employer healthcare solutions, including its Comprehensive Integrated Health Services Platform, which offers one comprehensive, digitally connected platform for educational institutions, corporations, insurers, and advisors to better manage the health and wellness of their students, employees, and customers.

CloudMD currently services a direct ecosystem of over 5,700 clinicians including, 1,800+ mental health practitioners, 1,600+ allied health professionals, 1,400+ doctors and nurses and covers 12 million individual lives across North America. For more information visit: https://investors.cloudmd.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

“Dr. Essam Hamza, MD”
Chief Executive Officer

FOR ADDITIONAL INFORMATION CONTACT:

Julia Becker
VP, Investor Relations
julia@cloudmd.ca
(604)785-0850

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FAQ

What was the reason for Mark Kohler's resignation from CloudMD?

Mark Kohler resigned as a director and Chair of the Board for personal reasons.

When did Mark Kohler resign from CloudMD?

Mark Kohler's resignation became effective on April 21, 2022.

How many clinicians does CloudMD currently service?

CloudMD services over 5,700 clinicians, including various healthcare professionals.

What impact might Mark Kohler's resignation have on CloudMD?

While it allows for new perspectives, it may also create concerns about leadership continuity.